An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Clinical trial NCT00250614 · COMPLETED

Trial details

NCT number: NCT00250614
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2005-04-01
Primary completion: 2006-10-01
Enrollment: 452

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.